Nombre del producto:N-[3-(1,3-benzothiazol-2-yl)-6-methyl-4H,5H,6H,7H-thieno[2,3-c]pyridin-2-yl]cyclohexanecarboxamide hydrochloride

IUPAC Name:N-[3-(1,3-benzothiazol-2-yl)-6-methyl-4H,5H,6H,7H-thieno[2,3-c]pyridin-2-yl]cyclohexanecarboxamide hydrochloride

CAS:1163144-10-2
Fórmula molecular:C22H26ClN3OS2
Pureza:95%+
Número de catálogo:CM642315
Peso molecular:448.04

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1163144-10-2
Fórmula molecular:C22H26ClN3OS2
Punto de fusión:-
Código de sonrisas:Cl.CN1CCC2=C(C1)SC(NC(=O)C1CCCCC1)=C2C1=NC2=CC=CC=C2S1
Densidad:
Número de catálogo:CM642315
Peso molecular:448.04
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Benzothiazoles
Benzothiazoles are aromatic heterocyclic compounds with the chemical formula C7H5NS. Benzothiazoles and their derivatives are a very important class of heterocyclic compounds that are ubiquitous in nature and are mainly used in medicine, agriculture and industry. In medicine, benzothiazole derivatives are a kind of very important pharmaceutical intermediates with good pharmacological and biological activities. It can be used as a fungicide, anti-tuberculosis drug, anti-malarial, anti-convulsant, insecticide, sedative and anti-inflammatory drug, and can also be used to treat diabetes and has anti-cancer effects.
Cyclohexanes
Cyclohexane is an organic compound with a chemical formula C6H12. It is a colorless liquid with a pungent odor, insoluble in water, and soluble in most organic solvents such as ethanol, ether, benzene, and acetone. Cyclohexyl fragments are a common structure in both natural and synthetic drugs. It can be used as both core structure and part of achiral side chain.
Thienopyridines
Thienopyridines are similar in structure to quinoline and isoquinoline, and are a class of heterocyclic compounds with important physiological activity and medicinal value. Thienopyridines are a subclass of antiplatelet drugs that prevent platelet aggregation by binding to selected extracellular cysteine residues on the P2Y12 receptor located on the platelet membrane.